GlassScriptPhysician profile
Andrew C Warner
NPI 1346505864
$1,354.29
in general payments reported to CMS, 2019-2025
14 companies · $893 in 2025
The $893 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.25 · 2023: $224 · 2024: $226 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $443.24 | 2025 | Rapiblyk |
| Bridgebio Pharma, INC. | $171.50 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $160.28 | 2023-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.34 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $80.60 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.55 | 2024-2025 | Jardiance |
| Abiomed | $68.81 | 2023-2025 | Impella |
| Nuwellis, INC. | $63.76 | 2024 | Aquadex Smartflow Console |
| Amgen INC. | $54.94 | 2024-2025 | Repatha |
| Kestra Medical Technology Services, INC. | $46.07 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $37.65 | 2023-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $23.00 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $16.30 | 2025 | |
| Medtronic, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.